Literature DB >> 7799524

Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.

M Yamano1, T Kamato, A Nishida, H Ito, H Yuki, R Tsutsumi, K Honda, K Miyata.   

Abstract

We investigated the mode of the 5-HT3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives, YM060, YM114 (KAE-393), YM-26103-2 and YM-26308-2, against 5-HT-induced transient bradycardia in anesthetized rats. Results were compared with those of ondansetron and granisetron. YM060 (0.03-0.1 microgram/kg, i.v.), YM114 (0.03-0.3 microgram/kg, i.v.), YM-26103-2 (0.01-0.03 microgram/kg, i.v.), YM-26308-2 (0.01-0.03 microgram/kg, i.v.) and granisetron (0.3-3 micrograms/kg, i.v.) displaced the 5-HT dose-response curve to the right, with apparent DR2 values of 0.068, 0.068, 0.019, 0.011 and 0.69 microgram/kg, i.v., respectively. Higher doses of these compounds inhibited 5-HT-induced bradycardia with a reduced maximal response. In contrast, ondansetron displaced the 5-HT dose-response curve to the right without affecting the maximal response. Judged by the apparent DR2 values, YM060, YM114, YM-26103-2 and YM-26308-2 were approximately 13, 13, 50 and 79 times more potent than ondansetron, respectively, whereas granisetron was equipotent to ondansetron. Single i.v. doses of YM060 and granisetron inhibited 5-HT-induced bradycardia significantly longer than ondansetron. Moreover, inhibitory effects of p.o. doses of YM060 (3 micrograms/kg), YM114 (80 micrograms/kg), YM-26103-2 (12 micrograms/kg), YM-26308-2 (5 micrograms/kg) and granisetron (250 micrograms/kg) on the von Bezold-Jarisch reflex lasted for 3-6 hr, whereas ondansetron (700 micrograms/kg, p.o.) antagonized 5-HT3 receptors for only 1 hr. In isolated guinea pig colon, the inhibitory effect of YM-compounds on 5-HT-induced contraction persisted significantly longer than those of ondansetron and granisetron after washout of the bath containing compounds.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7799524     DOI: 10.1254/jjp.65.241

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  8 in total

1.  Pharmacokinetic-pharmacodynamic modeling of the hydroxy lerisetron metabolite L6-OH in rats: an integrated parent-metabolite model.

Authors:  Fátima Ortega; Antonio Quintana; Elena Suárez; John C Lukas; Nerea Jauregizar; Leire de la Fuente; Maria Luisa Lucero; Ana Gonzalo; Aurelio Orjales; Rosario Calvo
Journal:  Pharm Res       Date:  2005-09-20       Impact factor: 4.200

2.  Effect of ondansetron on post-dural puncture headache (PDPH) in parturients undergoing cesarean section: a double-blind randomized placebo-controlled study.

Authors:  Zainabosadat Fattahi; Seyed Mohammad Reza Hadavi; Mohammad Ali Sahmeddini
Journal:  J Anesth       Date:  2015-03-27       Impact factor: 2.078

3.  Altered disposition and effect of lerisetron in rats with elevated alpha 1-acid glycoprotein levels.

Authors:  N Jauregizar; R Calvo; E Suarez; A Quintana; E Raczka; J C Lukas
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

4.  Effect of intravenous ondansetron on reducing the incidence of hypotension and bradycardia events during shoulder arthroscopy in sitting position under interscalene brachial plexus block: A prospective randomized trial.

Authors:  Srinivasa Rao Nallam; Sudheer Dara
Journal:  Indian J Anaesth       Date:  2015-06

5.  Comparing Two Different Doses of Intravenous Ondansetron With Placebo on Attenuation of Spinal-induced Hypotension and Shivering.

Authors:  Seyed Mojtaba Marashi; Saeid Soltani-Omid; Sussan Soltani Mohammadi; Yasaman Aghajani; Ali Movafegh
Journal:  Anesth Pain Med       Date:  2014-03-18

6.  Effect of Ondansetron on the Occurrence of Hypotension and on Neonatal Parameters during Spinal Anesthesia for Elective Caesarean Section: A Prospective, Randomized, Controlled, Double-Blind Study.

Authors:  Walid Trabelsi; Chihebeddine Romdhani; Haythem Elaskri; Walid Sammoud; Mohamed Bensalah; Iheb Labbene; Mustapha Ferjani
Journal:  Anesthesiol Res Pract       Date:  2015-01-08

7.  Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome.

Authors:  Toshimi Chiba; Kazunari Yamamoto; Shoko Sato; Kazuyuki Suzuki
Journal:  Clin Exp Gastroenterol       Date:  2013-07-25

8.  Effect of ondansetron on prevention of post-induction hypotension in elderly patients undergoing general anesthesia: A randomized, double-blind placebo-controlled clinical trial.

Authors:  Mohammad Golparvar; Mahmoud Saghaei; Mohammad Ali Saadati; Shadi Farsaei
Journal:  Saudi J Anaesth       Date:  2015 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.